Christopher Teas

Managing Partner at Park South Capital

Discussion leader

Christopher is Managing Partner and Co-Founder of Park South Capital (est. 2013), a Single-Family Office making majority control investments across Fintech, Biotech, Asset Management, U.S. Security and Defense, TMT and Banking sectors.

His 35+ year financial career includes leadership positions at Morgan Stanley, Belstar Group, Ticonderoga, and Southport Lane.

Christopher co-created the RepuSPX Algorithm on the S&P 500 in 2010 which has outperformed the S&P by over 340 basis points since inception. He currently serves as CEO of CAD Therapeutics, a clinical-stage biotech company treating PTSD and addiction.

His expertise spans building businesses, team management, complex transaction structuring, and early technology adoption. Christopher frequently speaks at conferences on: New Technologies, U.S. Security and Defense, AI, Alternative Asset Management, and Biotech.

He holds a BA from Lewis & Clark College and studied at Institut Catholique in Paris, France.